Hematoma Completed Phase 3 Trials for Dabigatran (DB14726)

Also known as: Hematomas / Haematoma / Haematoma NOS / Hematoma NOS

IndicationStatusPhase
DBCOND0023542 (Hematoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01675076Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic EventsTreatment